Health IT

Paris-based Ennov lands a major transatlantic investment to accelerate its AI platform, aiming to reshape global drug development and regulatory processes.

Massachusetts has approved a groundbreaking on-site technology that turns hazardous medical waste into recyclable material, disrupting the traditional disposal industry.

A new partnership embeds Eli Lilly's powerful AI models into CDD Vault, giving smaller biotechs unprecedented access to big pharma's discovery tools.

Sound Long-Term Care Management offers a lifeline to providers, proving value-based care can improve patient outcomes and financial performance.

A new AI model from Corti drastically reduces speech-to-text errors, promising a safer and more efficient 'agentic era' for healthcare technology.

A new Medicare policy aims to cut costs on medical supplies, but patient advocates warn it could endanger millions by restricting access to essential care.

Mispro's new contract vivarium at Genesis Science Center aims to provide crucial, flexible lab space for San Diego's burgeoning biotech startups.

The homegrown salon consolidates its brand into a new destination experience store in Arab Street, tapping into the booming modesty-conscious beauty market.

The 12th Annual Ride of Hope adds new challenging routes to honor Terry's legacy, channeling funds into cutting-edge precision cancer research.

West Coast Informatics' new offering shifts from static files to a managed FHIR service, aiming to ease the technical burden on standards organizations.

A first-in-class drug for anxiety has entered patient trials, offering a novel approach that could reshape mental healthcare for millions.

Two specialist investors are merging to create the world's largest dedicated healthcare fund, aiming to reshape global health innovation from West to East.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

A new partnership aims to solve one of biotech's biggest challenges, expanding powerful gene therapies beyond the liver to treat a wider range of diseases.

Ozari Health launches a nationwide service for affordable compounded semaglutide, navigating a complex and increasingly regulated market for GLP-1 drugs.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

ATxSummit 2026 highlights youth innovation and healthcare breakthroughs, cementing Singapore's role as a leader in ethical and impactful AI development.

A Rome-based medical spa is expanding access to cosmetic surgery across Central NY, filling a critical gap in high-level, physician-led aesthetic care.

From a 2024 startup to a global leader, see how Ascent Strategy Group used AI, cinematic storytelling, and a health equity mission to redefine the industry.